Tech Company Financing Transactions

Spruce Biosciences Funding Round

Spruce Biosciences, operating out of San Francisco, scored $88 million in funding from Abingworth, Omega Funds and Aisling Capital.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
Spruce intends to use the funds raised to evaluate tildacerfont to reduce glucocorticoid (GC) steroid usage in adults with CAH, and to complete proof-of-concept trials in children.

Company Information

Company Status
Mailing Address
1700 Montgomery St. 212
San Francisco, CA 94111
Email Address
Spruce Biosciences (Nasdaq: SPRB) is a clinical-stage biopharmaceutical based in San Francisco, California. Our mission is to develop meaningful therapies for patients with rare diseases affecting the hypothalamic-pituitary-adrenal (HPA) axis (the stress pathway).
Spruce Biosciences LinkedIn Company Profile
Social Media
Spruce Biosciences Company Twitter Account
Company News
Spruce Biosciences News
Spruce Biosciences on Facebook
Spruce Biosciences on YouTube

Management Team

Email & Social
Chief Executive Officer
Richard King
  Richard King LinkedIn Profile  Richard King Twitter Account  Richard King News  Richard King on Facebook
Chief Medical Officer
Kamal Bharucha
  Kamal Bharucha LinkedIn Profile  Kamal Bharucha Twitter Account  Kamal Bharucha News  Kamal Bharucha on Facebook
Chief Medical Officer
Michael Huang
  Michael Huang LinkedIn Profile  Michael Huang Twitter Account  Michael Huang News  Michael Huang on Facebook
Vice President
Chris Barnes
  Chris Barnes LinkedIn Profile  Chris Barnes Twitter Account  Chris Barnes News  Chris Barnes on Facebook
VP - Manufacturing
Sangita Ghosh
  Sangita Ghosh LinkedIn Profile  Sangita Ghosh Twitter Account  Sangita Ghosh News  Sangita Ghosh on Facebook
VP - Operations
David Moriarty
  David Moriarty LinkedIn Profile  David Moriarty Twitter Account  David Moriarty News  David Moriarty on Facebook
VP - Regulatory Affairs
Marc Lesnick
  Marc Lesnick LinkedIn Profile  Marc Lesnick Twitter Account  Marc Lesnick News  Marc Lesnick on Facebook



Browse more venture capital transactions:

Prev: 2/21/2020: EnClear Therapies venture capital transaction
Next: 2/21/2020: Feather venture capital transaction


Share this article


Where The Data Comes From

We do our best to record tech company VC transactions. VC transactions on this site are derived from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary